The Cambridge-based biotechnology firm made the announcement on Tuesday, saying that sales of Incivek, a drug to treat Hepatitis C, were expected to continue to decline as other treatments become available.
An advisory committee to the U.S "
Click here to read the whole article
The Massachusetts Accelerator for Biomanufacturing, a $31 million project, was designed to help early stage biotech companies that haveRead more
Healey will try and fill the AG spot as her boss runs for Massachusetts Governor. at a leading international law firm in Boston as a business and securities her practice on the financial services, technology, biotechnology,Read more